Newsletters - August 2004

Newsletters - August 2004

  1. You are here:  
  2. Home
  3. Newsletters - August 2004

Thomas Alva Edison Patent Award for Sabinsa Corporation

Sabinsa Corporation is winner of the Thomas Alva Edison Patent award for the year 2004 in the Consumer/Small Company category. The entry submitted was Sabinsa's patent on ForsLean®, US Patent # 5,804,596 titled "Method of Preparing a Forskolin Composition from Forskolin Extract and Use of Forskolin for Promoting Lean Body Mass and Treating Mood Disorders".

The annual Thomas Alva Edison Patent Awards instituted by The Research & Development Council of New Jersey honors the inventors of the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey . Awards are given in various industrial categories.

The 2003 categories of Consumer, Enabling Technology, Industrial, Information Technology and Medical Technology Transfer featured multinational giants such as AT&T, Bristol-Myers Squibb and Exxon-Mobil Research & Engineering, as winners. Earlier, Sabinsa Corporation was a finalist for the award in the Health & Medicine category in the year 1999 for the patent on Bioperine®.

This is the second award for ForsLean® in the innovation arena . The product earlier won the Best New Product award in 2001 at Nutracon.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.